| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 25 | +64.00% | +0.48% | +0.55% | -0.07% | -1.21% | — |
| 14d | 25 | +68.00% | -0.12% | -0.50% | +0.39% | -1.40% | — |
| 30d | 25 | +48.00% | +1.87% | -0.55% | +1.40% | +1.00% | — |
| 60d | 25 | +52.00% | +3.43% | -1.78% | +4.51% | +2.44% | — |
| 90d | 25(1 pending) | +37.50% | +8.61% | -0.66% | +7.92% | +4.70% | — |
| 180d | 25(6 pending) | +31.58% | +7.51% | +2.69% | +0.93% | +1.57% | — |
| 1y | 25(11 pending) | +50.00% | +5.52% | +9.30% | -3.78% | -11.19% | — |
| 2y | 25(21 pending) | +0.00% | +31.34% | +12.53% | +18.81% | +15.30% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 1,356 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 8,300 | $51.46 | $427.1K | 74,089 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 700 | $52.13 | $36.5K | 73,389 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 82,389 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 6,356 | Jun 1, 2026 | Jun 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 86,389 | Jun 1, 2026 | Jun 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 9,000 | $41.67 | $375.0K | 77,389 | Jun 1, 2026 | Jun 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 9,000 | $33.40 | $300.6K | 81,389 | May 1, 2026 | May 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 11,356 | May 1, 2026 | May 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 90,389 | May 1, 2026 | May 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 16,356 | Apr 1, 2026 | Apr 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 9,000 | $35.51 | $319.6K | 85,389 | Apr 1, 2026 | Apr 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 94,389 | Apr 1, 2026 | Apr 1, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 9,000 | $29.72 | $267.5K | 89,389 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 83,037 | — | — | 83,037 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 38,568 | — | — | 38,568 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 98,389 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 21,356 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 6,866 | — | — | 96,438 | Feb 26, 2026 | Feb 27, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,049 | $30.73 | $93.7K | 93,389 | Feb 26, 2026 | Feb 27, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 6,866 | — | — | 13,732 | Feb 26, 2026 | Feb 27, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 7,689 | — | — | 92,986 | Feb 23, 2026 | Feb 25, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,414 | $32.19 | $109.9K | 89,572 | Feb 23, 2026 | Feb 25, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 7,689 | — | — | 7,690 | Feb 23, 2026 | Feb 25, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 7,673 | — | — | 23,019 | Feb 19, 2026 | Feb 20, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,407 | $32.00 | $109.0K | 85,297 | Feb 19, 2026 | Feb 20, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 7,673 | — | — | 88,704 | Feb 19, 2026 | Feb 20, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 8,897 | — | — | 84,535 | Feb 18, 2026 | Feb 20, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 8,897 | — | — | 0 | Feb 18, 2026 | Feb 20, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,504 | $32.02 | $112.2K | 81,031 | Feb 18, 2026 | Feb 20, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 25,352 | — | — | 83,092 | Feb 5, 2026 | Feb 6, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 7,454 | $33.55 | $250.1K | 75,638 | Feb 5, 2026 | Feb 6, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 26,356 | Feb 2, 2026 | Feb 2, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 66,740 | Feb 2, 2026 | Feb 2, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 4,000 | $33.54 | $134.2K | 57,740 | Feb 2, 2026 | Feb 2, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 5,000 | $34.24 | $171.2K | 61,740 | Feb 2, 2026 | Feb 2, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 66,740 | Jan 8, 2026 | Jan 8, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 5,000 | $30.00 | $150.0K | 61,740 | Jan 8, 2026 | Jan 8, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 31,356 | Jan 8, 2026 | Jan 8, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 4,000 | $28.00 | $112.0K | 61,740 | Jan 2, 2026 | Jan 2, 2026 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,748 | — | — | 36,356 | Dec 3, 2025 | Dec 5, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 3,748 | $19.34 | $72.5K | 69,488 | Dec 3, 2025 | Dec 5, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 3,748 | $30.00 | $112.4K | 65,740 | Dec 3, 2025 | Dec 5, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 4,000 | $29.30 | $117.2K | 65,740 | Dec 1, 2025 | Dec 1, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 40,104 | Nov 3, 2025 | Nov 3, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 78,740 | Nov 3, 2025 | Nov 3, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 9,000 | $30.38 | $273.4K | 69,740 | Nov 3, 2025 | Nov 3, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,000 | — | — | 45,104 | Oct 15, 2025 | Oct 15, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 5,000 | $19.34 | $96.7K | 82,740 | Oct 15, 2025 | Oct 15, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 9,000 | $31.53 | $283.8K | 73,740 | Oct 15, 2025 | Oct 15, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 6,866 | — | — | 20,598 | Feb 26, 2025 | Feb 28, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,049 | $34.80 | $106.1K | 77,740 | Feb 26, 2025 | Feb 28, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 6,866 | — | — | 80,789 | Feb 26, 2025 | Feb 28, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 7,689 | — | — | 77,337 | Feb 23, 2025 | Feb 25, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 7,689 | — | — | 15,379 | Feb 23, 2025 | Feb 25, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,414 | $35.32 | $120.6K | 73,923 | Feb 23, 2025 | Feb 25, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 12,279 | — | — | 0 | Feb 22, 2025 | Feb 25, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 12,279 | — | — | 75,100 | Feb 22, 2025 | Feb 25, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,452 | $35.32 | $192.6K | 69,648 | Feb 22, 2025 | Feb 25, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 63,991 | — | — | 63,991 | Feb 19, 2025 | Feb 20, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 30,692 | — | — | 30,692 | Feb 19, 2025 | Feb 20, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 8,896 | — | — | 66,771 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,950 | $35.90 | $141.8K | 62,821 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 8,896 | — | — | 8,897 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 35,586 | $34.02 | $1.21M | 166,708 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 108,833 | — | — | 0 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 108,833 | $36.02 | $3.92M | 57,875 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 108,833 | $31.93 | $3.48M | 166,708 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 35,586 | $24.59 | $875.1K | 202,294 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 35,586 | — | — | 71,172 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 111,630 | $19.34 | $2.16M | 262,796 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 111,630 | — | — | 50,104 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 171,813 | $32.69 | $5.62M | 90,983 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 87,566 | — | — | 0 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 87,566 | $20.03 | $1.75M | 151,166 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 33,108 | $33.27 | $1.10M | 57,875 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 15,083 | $31.39 | $473.5K | 63,600 | Feb 6, 2025 | Feb 7, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 34,393 | — | — | 78,683 | Feb 6, 2025 | Feb 7, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 23,542 | $24.59 | $578.9K | 126,863 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 18,345 | $26.82 | $492.0K | 145,208 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 100,918 | $32.05 | $3.23M | 44,290 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 29,156 | $20.03 | $584.0K | 76,732 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 18,345 | — | — | 92,271 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 29,156 | — | — | 87,566 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 26,589 | — | — | 161,734 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 23,542 | — | — | 106,758 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 26,589 | $19.34 | $514.2K | 103,321 | Jan 30, 2025 | Jan 31, 2025 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 12,044 | — | — | 130,300 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 12,090 | — | — | 188,323 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 12,090 | $19.34 | $233.8K | 84,272 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 12,411 | — | — | 110,616 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 12,044 | $24.59 | $296.2K | 96,316 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 61,151 | $32.07 | $1.96M | 47,576 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 12,452 | $20.03 | $249.4K | 72,182 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 12,452 | — | — | 116,722 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 12,411 | $26.82 | $332.9K | 108,727 | Dec 9, 2024 | Dec 9, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 9,221 | $31.50 | $290.5K | 59,730 | Dec 5, 2024 | Dec 5, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 14,349 | $30.77 | $441.6K | 68,951 | Dec 4, 2024 | Dec 4, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 43,058 | — | — | 129,174 | Nov 11, 2024 | Nov 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 43,058 | $20.03 | $862.5K | 142,296 | Nov 11, 2024 | Nov 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 58,996 | $30.08 | $1.77M | 83,300 | Nov 11, 2024 | Nov 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE10b5-1 10b5-1 plan | 10,471 | $29.53 | $309.2K | 99,238 | Nov 6, 2024 | Nov 6, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 111,186 | — | — | 111,186 | Feb 26, 2024 | Feb 27, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 27,464 | — | — | 27,464 | Feb 26, 2024 | Feb 27, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,414 | $29.57 | $101.0K | 109,709 | Feb 23, 2024 | Feb 27, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 7,689 | — | — | 23,068 | Feb 23, 2024 | Feb 27, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 7,689 | — | — | 113,123 | Feb 23, 2024 | Feb 27, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,452 | $28.91 | $157.6K | 105,434 | Feb 22, 2024 | Feb 23, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 12,278 | — | — | 110,886 | Feb 22, 2024 | Feb 23, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 12,278 | — | — | 12,279 | Feb 22, 2024 | Feb 23, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 10,297 | — | — | 103,180 | Feb 20, 2024 | Feb 21, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 10,297 | — | — | 0 | Feb 20, 2024 | Feb 21, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 4,572 | $30.39 | $138.9K | 98,608 | Feb 20, 2024 | Feb 21, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 8,897 | — | — | 17,793 | Feb 18, 2024 | Feb 21, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 8,897 | — | — | 96,834 | Feb 18, 2024 | Feb 21, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,951 | $32.18 | $127.1K | 92,883 | Feb 18, 2024 | Feb 21, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 15,280 | $26.77 | $409.0K | 87,937 | Feb 8, 2024 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 46,658 | — | — | 103,217 | Feb 8, 2024 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 603 | — | — | 30,757 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 2,133 | $31.93 | $68.1K | 108,833 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 1,089 | $65.94 | $71.8K | 55,589 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 2,412 | $26.82 | $64.7K | 123,027 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 3,929 | $19.34 | $76.0K | 200,413 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 523 | — | — | 26,690 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 201 | — | — | 10,297 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 3,376 | $20.03 | $67.6K | 172,232 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 2,790 | $24.59 | $68.6K | 142,344 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 1,599 | $58.40 | $93.4K | 81,599 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 481 | — | — | 24,557 | Nov 17, 2023 | Feb 12, 2024 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 30,154 | — | — | 30,154 | Feb 23, 2023 | Feb 24, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 120,615 | — | — | 120,615 | Feb 23, 2023 | Feb 24, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,345 | $27.77 | $148.4K | 56,559 | Feb 22, 2023 | Feb 24, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 12,038 | — | — | 61,904 | Feb 22, 2023 | Feb 24, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 12,038 | — | — | 24,076 | Feb 22, 2023 | Feb 24, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 6,875 | — | — | 52,919 | Feb 21, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 6,875 | — | — | 0 | Feb 21, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,053 | $27.77 | $84.8K | 49,866 | Feb 21, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,780 | $28.07 | $106.1K | 30,375 | Feb 20, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 6,526 | $28.07 | $183.2K | 46,044 | Feb 20, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 10,095 | — | — | 10,096 | Feb 20, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 10,095 | — | — | 34,155 | Feb 20, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 22,195 | — | — | 52,570 | Feb 20, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 8,722 | — | — | 26,716 | Feb 18, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 8,722 | — | — | 26,167 | Feb 18, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 2,656 | $28.07 | $74.6K | 24,060 | Feb 18, 2023 | Feb 22, 2023 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 11,983 | $24.76 | $296.6K | 17,994 | Feb 23, 2022 | Feb 24, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 12,037 | — | — | 33,516 | Feb 22, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,539 | $25.01 | $88.5K | 29,977 | Feb 22, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 12,037 | — | — | 36,114 | Feb 22, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 2,022 | $25.08 | $50.7K | 21,479 | Feb 21, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 6,875 | — | — | 23,501 | Feb 21, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 6,875 | — | — | 6,875 | Feb 21, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 10,096 | — | — | 19,592 | Feb 20, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 10,096 | — | — | 20,191 | Feb 20, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 2,966 | $25.08 | $74.4K | 16,626 | Feb 20, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 34,889 | — | — | 34,889 | Feb 18, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 139,554 | — | — | 139,554 | Feb 18, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 2,306 | $25.17 | $58.0K | 9,496 | Feb 18, 2022 | Feb 23, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,375 | — | — | 0 | Feb 16, 2022 | Feb 17, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 3,375 | — | — | 12,871 | Feb 16, 2022 | Feb 17, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 1,069 | $26.79 | $28.6K | 11,802 | Feb 16, 2022 | Feb 17, 2022 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 5,647 | $30.60 | $172.8K | 9,496 | Sep 14, 2021 | Sep 16, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 15,143 | — | — | 15,143 | Sep 14, 2021 | Sep 16, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 882 | $24.60 | $21.7K | 0 | Jun 9, 2021 | Jun 11, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 1,250 | — | — | 0 | Jun 7, 2021 | Jun 8, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 368 | $23.50 | $8.6K | 882 | Jun 7, 2021 | Jun 8, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 1,250 | — | — | 1,250 | Jun 7, 2021 | Jun 8, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 28,920 | $19.72 | $570.3K | 0 | Apr 15, 2021 | Apr 16, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 196,484 | — | — | 196,484 | Feb 22, 2021 | Feb 24, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 48,151 | — | — | 48,151 | Feb 22, 2021 | Feb 24, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 2,022 | $19.58 | $39.6K | 28,920 | Feb 21, 2021 | Feb 23, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 6,875 | — | — | 13,750 | Feb 21, 2021 | Feb 23, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 6,875 | — | — | 30,942 | Feb 21, 2021 | Feb 23, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,064 | $19.58 | $60.0K | 24,067 | Feb 20, 2021 | Feb 23, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 10,095 | — | — | 27,131 | Feb 20, 2021 | Feb 23, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 10,095 | — | — | 30,287 | Feb 20, 2021 | Feb 23, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 1,172 | $19.79 | $23.2K | 17,036 | Feb 16, 2021 | Feb 18, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,375 | — | — | 3,375 | Feb 16, 2021 | Feb 18, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 3,375 | — | — | 18,208 | Feb 16, 2021 | Feb 18, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 1,250 | — | — | 15,201 | Jun 7, 2020 | Jun 8, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 368 | $17.19 | $6.3K | 14,833 | Jun 7, 2020 | Jun 8, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 1,250 | — | — | 1,250 | Jun 7, 2020 | Jun 8, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 6,875 | — | — | 99,825 | Feb 21, 2020 | Feb 24, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 2,004 | $20.24 | $40.6K | 13,951 | Feb 21, 2020 | Feb 24, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 6,875 | — | — | 15,955 | Feb 21, 2020 | Jan 15, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 6,875 | — | — | 20,625 | Feb 21, 2020 | Jan 15, 2021 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 6,875 | — | — | 15,955 | Feb 21, 2020 | Feb 24, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 168,856 | — | — | 168,856 | Feb 20, 2020 | Feb 24, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASEGRANT Stock grant | 40,382 | — | — | 40,382 | Feb 20, 2020 | Feb 24, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 3,375 | — | — | 6,750 | Feb 16, 2020 | Feb 18, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | PURCHASE EVP R&D, Chief Medical Officer | 3,375 | — | — | 10,252 | Feb 16, 2020 | Feb 18, 2020 ↗ | View → |
| ALKS ALKERMES PLC. | SALE EVP R&D, Chief Medical Officer | 1,172 | $17.77 | $20.8K | 9,080 | Feb 16, 2020 | Feb 18, 2020 ↗ | View → |